Desamparados Roda

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

N. Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella et al. · Annals of Oncology · 2019 · 275 citations · Full text

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with <i>BRCA1/2</i> - and Non– <i>BRCA1/2</i> -Mutant Cancers

Timothy A. Yap, Rebecca Kristeleit, Vasiliki Michalarea et al. · Cancer Discovery · 2020 · 130 citations · Full text

Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

Luis Paz‐Ares, Carlos Gomez‐Roca, Jean‐Pierre Delord et al. · Journal of Clinical Oncology · 2011 · 81 citations

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”

Federica Papaccio, Blanca García-Micó, Francisco Gimeno-Valiente et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 81 citations · Full text